Company Quick10K Filing
Cheniere Energy Partners
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 232 $7,546
10-Q 2018-08-09 Quarter: 2018-06-30
10-Q 2018-05-04 Quarter: 2018-03-31
10-K 2018-02-21 Annual: 2017-12-31
10-Q 2017-11-09 Quarter: 2017-09-30
10-Q 2017-08-08 Quarter: 2017-06-30
10-Q 2017-05-04 Quarter: 2017-03-31
10-K 2017-02-24 Annual: 2016-12-31
10-Q 2016-11-03 Quarter: 2016-09-30
10-Q 2016-08-09 Quarter: 2016-06-30
10-Q 2016-05-05 Quarter: 2016-03-31
10-K 2016-02-19 Annual: 2015-12-31
10-Q 2015-10-30 Quarter: 2015-09-30
10-Q 2015-07-30 Quarter: 2015-06-30
10-Q 2015-04-30 Quarter: 2015-03-31
10-K 2015-02-20 Annual: 2014-12-31
10-Q 2014-10-30 Quarter: 2014-09-30
10-Q 2014-07-31 Quarter: 2014-06-30
10-Q 2014-05-01 Quarter: 2014-03-31
10-K 2014-02-21 Annual: 2013-12-31
8-K 2018-09-20 M&A, Shareholder Rights, Officers, Amend Bylaw, Shareholder Vote, Regulation FD, Exhibits
8-K 2018-09-06 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2018-09-06 Regulation FD, Exhibits
8-K 2018-09-06 Regulation FD, Exhibits
8-K 2018-08-27 Regulation FD, Exhibits
8-K 2018-08-10 Regulation FD, Exhibits
8-K 2018-08-09 Earnings, Exhibits
8-K 2018-06-18 Enter Agreement, Regulation FD, Exhibits
8-K 2018-05-16 Other Events, Exhibits
8-K 2018-05-08 Regulation FD, Exhibits
8-K 2018-05-04 Earnings, Exhibits
8-K 2018-03-16 Regulation FD, Exhibits
8-K 2018-02-21 Earnings, Exhibits
8-K 2018-02-06 Regulation FD, Exhibits

Cheniere Energy Partners Financials

CQH Metrics, Comps, Filings

Annual | Quarterly

Business

We are a publicly traded Delaware limited liability company formed by Cheniere in 2013 to hold its limited partner interests in Cheniere Partners, a publicly traded limited partnership. Our only business consists of owning and holding Cheniere Partners' limited partner common units and subordinated units (collectively, the "Cheniere Partners units"), along with cash or other property that we receive as distributions in respect of such units, and, accordingly, our operating results and financial condition are dependent on the performance of Cheniere Partners. Therefore, Cheniere Partners' Annual Report on Form 10-K for the year ended December 31, 2017, has been included in this filing as Exhibit 99.1 and incorporated herein by reference (the "Cheniere Partners Annual Report").

Cheniere Partners is developing, constructing and operating natural gas liquefaction facilities at the Sabine Pass LNG terminal located in Cameron Parish, Louisiana, on the Sabine-Neches Waterway less than four miles from the Gulf Coast adjacent to the existing regasification facilities through its wholly owned subsidiary, SPL. The liquefaction of natural gas into LNG allows it to be shipped economically from areas of the world where natural gas is abundant and inexpensive to produce to other areas where natural gas demand and infrastructure exist to economically justify the use of LNG. Cheniere Partners owns and operates the LNG regasification facilities at the Sabine Pass LNG terminal through its wholly owned subsidiary, SPLNG. Cheniere Partners also owns a 94-mile pipeline that interconnects the Sabine Pass LNG terminal with a number of large interstate pipelines through its wholly owned subsidiary, CTPL.

When Cheniere Partners makes cash distributions to us with respect to the Cheniere Partners units, we will pay dividends to our shareholders consisting of the cash that we receive from Cheniere Partners, less income taxes and reserves established by our Board of Directors (our "Board"). In accordance with the terms of the Fourth Amended and Restated Agreement of Limited Partnership of Cheniere Partners, dated as of February 14, 2017 (the "Partnership Agreement"), Cheniere Partners paid the initial quarterly distribution amounts of $0.425 per common unit, or $1.70 per common unit on an annualized basis, for each fiscal quarter since its initial public offering in March 2007 through the quarter ended June 30, 2017. Cheniere Partners increased its quarterly cash distributions to $0.44 per common unit with respect to the quarter ended September 30, 2017 and to $0.50 per common unit with respect to the quarter ended December 31, 2017. Cheniere Partners did not make any cash distributions on its subordinated units with respect to the quarter ended June 30, 2010 through the quarter ended June 30, 2017, but resumed making cash distributions with respect to the quarter ended September 30, 2017.


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Stockholders' Equity

Income Statement ($BB Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($BB Annual)

Operating, Investing, Financing

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Image Chain Group (ICGL) 10,171 -2% -2,544.7 0 1 -0 0 -4 -4 10,171
Simply Good Foods (ATK) 9,838 48% 111.2 5% 1,125 295 492 235 53 88 9,787
Beyond Meat (BYND) 9,802 31% -902.3 -4% 397 65 107 34 -16 -11 9,555
Tradeweb Markets (TW) 9,176 0% 135.5 0% 5,072 618 190 0 25 65 8,861
Levi Strauss (LEVI) 8,797 54% 12.5 10% 3,909 2,588 5,733 3,072 402 716 8,946
CrowdStrike Holdings (CRWD) 8,438 70% -100.8 -7% 1,172 443 204 143 -78 -76 7,705
Fibria Celulose (FBR) 8,093 0% 38,693 24,043 0 0 0 0 4,853
Delcath Systems (DCTH) 7,928 196% -238.4 -596% 6 35 1 2 -34 -33 7,937
World Gold Trust (GLDW) 7,880 86.5 11% 826 0 0 0 91 91 7,880
Cheniere Energy Partners (CQH) 7,546 0% 21.1 40,650% 1 0 106 0 357 358 7,546
Scana (SCG) 6,991 0% -22.6 -3% 17,654 6,357 4 0 -589 -609 13,783
Great Plains Energy (GXP) 6,623 9.2 2% 12,448 3,898 0 0 201 986 9,090
DCT Industrial Trust (DCT) 6,436 0% 22.8 3% 4,083 2,007 434 0 125 360 8,200
Energen (EGN) 6,424 0% 9.0 7% 5,724 2,116 1,382 0 423 814 7,362
EQGP Holdings (EQGP) 6,194 0% 7.5 8% 9,268 4,213 867 0 701 829 6,188
Michael Kors (KORS) 5,769 61% 10.0 5% 8,308 5,980 5,382 3,263 402 802 8,054
Validus (VR) 5,456 -20% -37.2 -1% 15,499 9,928 2,881 -578 -193 -141 5,235
Envision Healthcare (EVHC) 5,406 0% -9.8 -13% 12,313 7,687 8,144 0 -1,555 -960 9,409
Carey Watermark Investors (CWI) 5,170 0% 50.7 -1% 2,287 1,568 622 0 -20 127 6,428
Foundation Medicine (FMI) 5,074 0% -42.1 -73% 193 202 201 0 -142 -119 5,019

Balance Sheet ($MM)2014-06-302014-12-312015-12-312016-12-312017-12-31
Cash3071101
Accounts Receivable000
Inventory6
PP&E7,815
Assets10,7122101
Accounts Payable270
Long-Term Debt8,986
Liabilities9,4180000
Stockholders' Equity1,2941101
Income Statement ($MM)2014-06-302014-12-312015-12-312016-12-312017-12-31
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A1121
Tax
Net Income181818118
Cash Flow ($MM)2014-06-302014-12-312015-12-312016-12-312017-12-31
Cash Operating-2-2-2-2
Cash Investing
Cash Financing-17-19-19-118